- Markets
- Chemicals
- PAR
PAR
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Par Drugs And Chemicals Gets Show Cause Notice Issued With Demand Of 2.5 Mln Rupees
Jan 22 (Reuters) - Par Drugs and Chemicals Ltd PARR.NS:
GETS SHOW CAUSE NOTICE ISSUED WITH DEMAND OF 2.5 MILLION RUPEES
Source text: ID:nNSE4mjlmy
Further company coverage: PARR.NS
(([email protected];;))
Jan 22 (Reuters) - Par Drugs and Chemicals Ltd PARR.NS:
GETS SHOW CAUSE NOTICE ISSUED WITH DEMAND OF 2.5 MILLION RUPEES
Source text: ID:nNSE4mjlmy
Further company coverage: PARR.NS
(([email protected];;))
India's Par Drugs and Chemicals slumps on establishment sale
** Par Drugs and Chemicals PARR.NS falls to exchange-allowed lower band of 20% to 278.80 rupees
** Pharma co approves sale of existing establishment, including land, building, plant and machinery for 928.8 mln rupees ($11 mln)
** Establishment contributed 99.4% to co's net rev
** Co will enter clean and renewable energy, real-estate and construction, and capital market businesses
** Says will use ~270 mln rupees of the sale proceeds in real-estate and construction business, ~250 mln rupees for clean energy and ~410 mln rupees for capital market business
** PARR sees worst intraday pct drop since listing in 2021
** Around 1.1 mln shares traded, 4.7x the 30-day avg
** Day's losses trim YTD gains to ~30%
($1 = 84.6460 Indian rupees)
(Reporting by Vijay Malkar)
(([email protected];))
** Par Drugs and Chemicals PARR.NS falls to exchange-allowed lower band of 20% to 278.80 rupees
** Pharma co approves sale of existing establishment, including land, building, plant and machinery for 928.8 mln rupees ($11 mln)
** Establishment contributed 99.4% to co's net rev
** Co will enter clean and renewable energy, real-estate and construction, and capital market businesses
** Says will use ~270 mln rupees of the sale proceeds in real-estate and construction business, ~250 mln rupees for clean energy and ~410 mln rupees for capital market business
** PARR sees worst intraday pct drop since listing in 2021
** Around 1.1 mln shares traded, 4.7x the 30-day avg
** Day's losses trim YTD gains to ~30%
($1 = 84.6460 Indian rupees)
(Reporting by Vijay Malkar)
(([email protected];))
Par Drugs And Chemicals Approves Slump Sale Of Existing Establishment
Dec 2 (Reuters) - Par Drugs and Chemicals Ltd PARR.NS:
PAR DRUGS AND CHEMICALS - APPROVED SLUMP SALE OF EXISTING ESTABLISHMENT
PAR DRUGS AND CHEMICALS - TO ENTER INTO BUSINESS OF CLEAN, RENEWABLE ENERGY
PAR DRUGS AND CHEMICALS - TO VENTURE IN TO BUSINESS OF REAL-ESTATE, CONSTRUCTION
PAR DRUGS AND CHEMICALS - TO MAKE VENTURING IN TO CAPITAL MARKET
PAR DRUGS AND CHEMICALS - SLUMP SALE OF EXISTING ESTABLISHMENT FOR 928.8 MILLION RUPEES
Source text: ID:nNSE38LJCB
Further company coverage: PARR.NS
(([email protected];))
Dec 2 (Reuters) - Par Drugs and Chemicals Ltd PARR.NS:
PAR DRUGS AND CHEMICALS - APPROVED SLUMP SALE OF EXISTING ESTABLISHMENT
PAR DRUGS AND CHEMICALS - TO ENTER INTO BUSINESS OF CLEAN, RENEWABLE ENERGY
PAR DRUGS AND CHEMICALS - TO VENTURE IN TO BUSINESS OF REAL-ESTATE, CONSTRUCTION
PAR DRUGS AND CHEMICALS - TO MAKE VENTURING IN TO CAPITAL MARKET
PAR DRUGS AND CHEMICALS - SLUMP SALE OF EXISTING ESTABLISHMENT FOR 928.8 MILLION RUPEES
Source text: ID:nNSE38LJCB
Further company coverage: PARR.NS
(([email protected];))
Par Drugs And Chemicals Got GST Notice Demanding 5.2 Mln Rupees
Dec 28 (Reuters) - Par Drugs and Chemicals Ltd PARR.NS:
GOT GST NOTICE DEMANDING 5.2 MILLION RUPEES
Further company coverage: PARR.NS
(([email protected];))
Dec 28 (Reuters) - Par Drugs and Chemicals Ltd PARR.NS:
GOT GST NOTICE DEMANDING 5.2 MILLION RUPEES
Further company coverage: PARR.NS
(([email protected];))
Events:
Dividend
Bonus
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Par Drugs & Chem. do?
Par Drugs and Chemicals Limited specializes in manufacturing Active Pharma Ingredients and fine chemicals for domestic and international markets to be used in various forms of dosage.
Who are the competitors of Par Drugs & Chem.?
Par Drugs & Chem. major competitors are Polson, Alkali Metals, Resonance Specialtie, Archit Organosys, IVP, Oriental Carbon&Chem, Kanchi Karpooram. Market Cap of Par Drugs & Chem. is ₹130 Crs. While the median market cap of its peers are ₹149 Crs.
Is Par Drugs & Chem. financially stable compared to its competitors?
Par Drugs & Chem. seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Par Drugs & Chem. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Par Drugs & Chem. latest dividend payout ratio is 16.69% and 3yr average dividend payout ratio is 16.69%
How has Par Drugs & Chem. allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Par Drugs & Chem. balance sheet?
Balance sheet of Par Drugs & Chem. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Par Drugs & Chem. improving?
Yes, profit is increasing. The profit of Par Drugs & Chem. is ₹15.43 Crs for TTM, ₹14.5 Crs for Mar 2024 and ₹11.33 Crs for Mar 2023.
Is the debt of Par Drugs & Chem. increasing or decreasing?
Yes, The debt of Par Drugs & Chem. is increasing. Latest debt of Par Drugs & Chem. is -₹18.78 Crs as of Sep-24. This is greater than Mar-24 when it was -₹73.29 Crs.
Is Par Drugs & Chem. stock expensive?
Par Drugs & Chem. is not expensive. Latest PE of Par Drugs & Chem. is 8.43, while 3 year average PE is 18.73. Also latest EV/EBITDA of Par Drugs & Chem. is 4.8 while 3yr average is 10.79.
Has the share price of Par Drugs & Chem. grown faster than its competition?
Par Drugs & Chem. has given better returns compared to its competitors. Par Drugs & Chem. has grown at ~41.78% over the last 5yrs while peers have grown at a median rate of 19.59%
Is the promoter bullish about Par Drugs & Chem.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Par Drugs & Chem. is 73.37% and last quarter promoter holding is 73.37%.
Are mutual funds buying/selling Par Drugs & Chem.?
There is Insufficient data to gauge this.